APA (7th ed.) Citation

FE, D., T, A., R, d. B., I, H., L, L., A, C., . . . P, v. d. M. (2026). Plasma proteomics stratification identifies phospholamban R14del carriers at risk for disease progression. Cardiovascular research, 122(8), 1104. https://doi.org/10.1093/cvr/cvag089

Chicago Style (17th ed.) Citation

FE, Deiman, et al. "Plasma Proteomics Stratification Identifies Phospholamban R14del Carriers at Risk for Disease Progression." Cardiovascular Research 122, no. 8 (2026): 1104. https://doi.org/10.1093/cvr/cvag089.

MLA (9th ed.) Citation

FE, Deiman, et al. "Plasma Proteomics Stratification Identifies Phospholamban R14del Carriers at Risk for Disease Progression." Cardiovascular Research, vol. 122, no. 8, 2026, p. 1104, https://doi.org/10.1093/cvr/cvag089.